Montclair State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Montclair State University sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Montclair State University: 8 sponsored US clinical trials, 3 recruiting.
Montclair State University sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Speech Sound Disorder, with 3 trials.
Upper-quartile sponsor footprint
Montclair State University sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
BiOfeedback, Online for Sibilant Treatment
NCT07041723
Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
NCT06969521
Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities
NCT06904508
Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics
NCT07344740
Language Learning and Language Experience
NCT06645145
The Effect of Articulatory Gestures on Early Literacy Skills in 4-year Olds
NCT06504264
Auditory-Perceptual Training Via Telepractice
NCT04858035
Visual Acoustic Biofeedback for RSE Via Telepractice
NCT04858022
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Montclair State University pipeline
3 recruiting of 8 indexed (38% open); 4 completed (50%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Speech Sound Disorder (3 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Montclair State University: open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Montclair State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 38% open enrollment (± trial volume)
- American Thrombosis and Hemostasis Network · 38% recruiting · 8 trials
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
Related
What to do with this Montclair State University page
8 registered trials is a research-attention snapshot, not an endorsement of Montclair State University or any single study.
- 3 of Montclair State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Speech Sound Disorder is the condition Montclair State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Speech Sound Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Montclair State University pipeline card: 8 registered trials from official public datasets.Report a data error.